2022
DOI: 10.5603/rpor.a2022.0121
|View full text |Cite
|
Sign up to set email alerts
|

Helical tomotherapy experience in breast cancer adjuvant radiotherapy and acute toxicity results

Abstract: Background: This study aimed to evaluate acute toxicity and oncological outcomes of breast cancer patients who underwent adjuvant radiotherapy (RT) with tomotherapy. Materials and methods:The results of 114 patients who underwent adjuvant RT with Tomotherapy device between 17.08.10-12.06.2021 in XXX Hospital were evaluated retrospectively. The primary endpoint of the study was acute adverse events, and the secondary endpoints were overall survival (OS) and disease-free survival (DFS). Results:The results of 10… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Among all the vital constituents of breast cancer treatment, adjuvant radiotherapy (RT) plays a paramount role in substantially enhancing overall survival rate and effectively reducing risk of localized cancer recurrence [ 1 , 2 ]. Recent developments in RT techniques have shown that Tomotherapy can be employed to achieve optimal target coverage through meticulous dose painting, which results in improving tumor control probability and reducing normal tissue complications in comparison with traditional techniques [ 3 5 ]. Nonetheless, considering patient’s quality of life and undesirable treatment interruptions, acute skin toxicity (AST) remains a notable concern in breast cancer RT [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Among all the vital constituents of breast cancer treatment, adjuvant radiotherapy (RT) plays a paramount role in substantially enhancing overall survival rate and effectively reducing risk of localized cancer recurrence [ 1 , 2 ]. Recent developments in RT techniques have shown that Tomotherapy can be employed to achieve optimal target coverage through meticulous dose painting, which results in improving tumor control probability and reducing normal tissue complications in comparison with traditional techniques [ 3 5 ]. Nonetheless, considering patient’s quality of life and undesirable treatment interruptions, acute skin toxicity (AST) remains a notable concern in breast cancer RT [ 6 ].…”
Section: Introductionmentioning
confidence: 99%